financetom
Business
financetom
/
Business
/
BRIEF-MBX Biosciences, Inc - Expect IPO Offering Price Will Be Between $14.00 And $16.00 Per Share
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-MBX Biosciences, Inc - Expect IPO Offering Price Will Be Between $14.00 And $16.00 Per Share
Sep 11, 2024 12:33 AM

Sept 9 (Reuters) -

* MBX BIOSCIENCES, INC - EXPECT IPO OFFERING PRICE WILL BE

BETWEEN

$14.00 AND $16.00 PER SHARE

* MBX BIOSCIENCES, INC SEES IPO OF UP TO 8.5 MILLION SHARES

OF

COMMON STOCK - SEC FILING

Source text for Eikon:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
International Clean Power Dividend Fund Approves Conversion Into Infrastructure Dividend Split Corp.
International Clean Power Dividend Fund Approves Conversion Into Infrastructure Dividend Split Corp.
May 1, 2024
05:27 PM EDT, 05/01/2024 (MT Newswires) -- International Clean Power Dividend Fund (CLP-UN.TO) said Wednesday a special meeting of unitholders voted in favour of a resolution approving the previously announced merger of CLP into Infrastructure Dividend Split Corp., a newly formed split share corporation. The Merger is expected to be completed on May 4.. CLP unitholders will receive Class A...
Cts Insider Sold Shares Worth $2,064,439, According to a Recent SEC Filing
Cts Insider Sold Shares Worth $2,064,439, According to a Recent SEC Filing
May 1, 2024
05:25 PM EDT, 05/01/2024 (MT Newswires) -- Kieran M O'Sullivan, Director, President & CEO, on April 29, 2024, sold 43,855 shares in Cts (CTS) for $2,064,439. Following the Form 4 filing with the SEC, O'Sullivan has control over a total of 455,643 shares of the company, with 455,643 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/26058/000095017024051403/xslF345X03/ownership.xml Price: 47.42, Change: -0.03, Percent Change:...
Franco-Nevada Edges Up After Hours as Its Q1 Profit and Revenue Fall After Cobre Panama Suspension
Franco-Nevada Edges Up After Hours as Its Q1 Profit and Revenue Fall After Cobre Panama Suspension
May 1, 2024
05:26 PM EDT, 05/01/2024 (MT Newswires) -- Franco-Nevada ( FNV ) edged uo in after-hours New York trading after the company on Wednesday said its first-quarter profit and revenue dropped following last year's suspension of operations at First Quantum Minerals (FM.TO) Cobre Panama mine, the royalty and streaming company's largest investment. The company said its profit in the quarter fell...
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing
May 1, 2024
05:27 PM EDT, 05/01/2024 (MT Newswires) -- Jean-Luc M Lemercier, Corporate Vice President, EMEA, Canada, Latin America and Japan, Greater China and Asia Pacific, on May 01, 2024, sold 14,400 shares in Edwards Lifesciences ( EW ) for $1,212,687. Following the Form 4 filing with the SEC, Lemercier has control over a total of 173,849 shares of the company, with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved